Tyrvaya increases Schirmer score in dry eye patients
July 06, 2022
1 minute watch
O’Dell L, et al. Effect of OC-01 nasal spray (varenicline solution) versus vehicle control on dry eye sign scores by baseline subgroup characteristics.
O’Dell declares to be a member of the advisory board of Oyster Point Pharma.
CHICAGO – Tyrvaya nasal spray was shown to increase Schirmer scores within 4 weeks in the ONSET-1 and ONSET-2 clinical trials, Leslie O’Dell, DO, said at the optometry meeting.
Patients using OC-01 or Tyrvaya (Varenicline Solution 0.03 mg, Oyster Point Pharma) increased by 5.5 mm whether or not they started with mild or severe dry eye disease, she said. .